During the past decade, University Hospitals Sharon Health Center conducted 63 clinical trials. In the 10-year time frame, 63 clinical trials started and 26 clinical trials were completed, i.e. on average, 41.3% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 25 clinical trials were completed. i.e. 119% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University Hospitals Sharon Health Center" #1 sponsor was "National Cancer Institute (NCI)" with 32 trials, followed by "SWOG Cancer Research Network" with 20 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 6 trials sponsored and "NRG Oncology" with 6 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University Hospitals Sharon Health Center" #1 collaborator was "National Cancer Institute (NCI)" with 38 trials as a collaborator, "NRG Oncology" with 17 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "Alliance for Clinical Trials in Oncology" with 1 trials as a collaborator and "Astellas Pharma US, Inc." with 1 trials as a collaborator. Other collaborators include 5 different institutions and companies that were collaborators in the rest 15 trials.

According to Clinical.Site data, the most researched conditions in "University Hospitals Sharon Health Center" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Recurrent Ovarian Carcinoma" (7 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Invasive Breast Carcinoma" (4 trials). Many other conditions were trialed in "University Hospitals Sharon Health Center" in a lesser frequency.

Most popular intervention types in "University Hospitals Sharon Health Center" are "Drug" (59 trials), "Other" (45 trials), "Biological" (31 trials), "Procedure" (19 trials) and "Radiation" (10 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (23 trials), "Quality-of-Life Assessment" (17 trials), "Computed Tomography" (14 trials), "Biospecimen Collection" (11 trials) and "Docetaxel" (10 trials). Other intervention names were less common.

The vast majority of trials in "University Hospitals Sharon Health Center" are 49 trials for "All" genders, 21 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University Hospitals Sharon Health Center". undefined are not yet recruiting, 21 are recruiting, 35 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in University Hospitals Sharon Health Center, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in University Hospitals Sharon Health Center, 0 "Phase 1" clinical trials were conducted, 35 "Phase 2" clinical trials and 41 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".

University Hospitals Sharon Health Center has several departments that took part in Clinical trials: "UH Seidman Cancer Center at Saint John Medical Center" - 87 trials, "Ireland Cancer Center" - 273 trials, "UH Seidman Cancer Center at Landerbrook Health Center" - 44 trials, "UH Seidman Cancer Center at UH Avon Health Center" - 3 trials